Literature DB >> 16398216

Relationship between angiogenesis and grade of histologic differentiation in endometrial adenocarcinoma.

N M de Góis Speck1, J Focchi, A C Alves, J C L Ribalta, C A B Osório.   

Abstract

The objective of the study was to quantify vessels and to relate them to the degree of histologic differentiation in endometrial adenocarcinoma. We studied 35 cases of which ten were G1, 13 G2 and 12 G3 adenocarcinomas. The control group consisted of 11 atrophic and 10 proliferative endometria. From each case two histologic sections were obtained: one for hematoxylin-eosin staining and the other for immunohistochemical study with anti-CD34. Vessel count was performed by morphometric study. Mean vessel count was 15.3 for G1; 19 for G2 and 22.7 for G3 adenocarcinomas; in the control group it was 11.6 for atrophic and 13.2 for proliferative endometria. Slightly differentiated adenocarcinoma presented greater angiogenesis than normal and well-differentiated carcinoma. In contrast, moderately differentiated carcinoma showed greater angiogenicity as related to normal endometrium, but did not differ from other tumoral endometria.

Entities:  

Mesh:

Year:  2005        PMID: 16398216

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  2 in total

1.  The pattern of expression of Notch protein members in normal and pathological endometrium.

Authors:  Luigi Cobellis; Francesca Caprio; Elisabetta Trabucco; Annunziata Mastrogiacomo; Gabriele Coppola; Lucrezia Manente; Nicola Colacurci; Maria De Falco; Antonio De Luca
Journal:  J Anat       Date:  2008-08-04       Impact factor: 2.610

2.  Clinicopathological analysis of factors related to colorectal tumor perforation: influence of angiogenesis.

Authors:  Vicente Medina-Arana; Antonio Martínez-Riera; Luciano Delgado-Plasencia; Diana Rodríguez-González; Alberto Bravo-Gutiérrez; Hugo Álvarez-Argüelles; Antonio Alarcó-Hernández; Eduardo Salido-Ruiz; Antonia M Fernández-Peralta; Juan J González-Aguilera
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.